Answered on : 2024-01-24
Yes, there appears to be a logical contradiction in Xerox's actions. While investing heavily in pure research sites like PARC, Xerox failed to capitalize commercially on the innovative products developed, creating a disconnect between research efforts and commercialization strategies [1]. This contradiction raises questions about the alignment of Xerox's research and business objectives.
1. Xerox's willingness to fund research sites like PARC demonstrates commitment to innovation [1].
However, this commitment is contradicted by:
- Refusal to bring developed products to the market [1].
This contradiction has been acknowledged in various sources, emphasizing the missed opportunities for commercial success resulting from this misalignment [1] [7] [9].